On growth path with top-class medicine
| Investor News
On growth path with top-class medicine: M1 Kliniken AG increases sales by +30% in the first half of 2018
- Sales EUR 28.9 million (H1/17: EUR 22.3 million)
- EBT EUR 4.28 million (H1/17: EUR 4.24 million); margin within target corridor
- Investments made for further growth: New specialty centers, new treatment areas and international expansion in the second half of 2018
- Positive outlook: sales and earnings to be further increased
Berlin, 27.08.2018 – M1 Kliniken AG (ISIN: DE000A0STSQ8) continued its growth path in the first half of 2018 and increased sales by 30% from EUR 22.3 million to EUR 28.9 million. As the leading private provider of health services in the field of beauty medicine in Germany, the group is benefiting with its brand “M1 Med Beauty” from the growing demand for plastic and aesthetic treatments.
“The utilisation of our 20 ambulatory specialist centres for beauty treatments and the Schlossklinik in Berlin has developed satisfactorily. After opening five specialist centers in the second half of 2017, we were able to put two more centers into operation in the first half of this year,” says Dr. Walter von Horstig, member of the Management Board of M1 Kliniken AG. “In addition to operational growth, we have also invested in the future. Among other things, we opened the first center for aesthetic dental treatment in our clinic in Berlin. In recent months we have been able to establish medical and business processes in order to quickly expand throughout Germany with the new “M1 Dental” brand.“
Despite the up-front costs of the large number of new locations and investments in new treatment areas, the M1 Group continues to grow profitably: earnings before tax (EBT) in the first half of 2018 were at EUR 4.3 million (H1 2017: EUR 4.2 million). The EBT margin is thus in the targeted corridor.
Positive outlook: New specialist centres, entry into aesthetic dentistry and international expansion
M1 Kliniken is confident about the second half of 2018 and beyond. As a result of the specialist centers currently in operation, sales and EBT will continue to rise compared with the same period of the previous year and the first half of the year. Further locations are also planned. The range of services for cosmetic treatments is to be expanded in all specialist centres. In addition, the first locations for aesthetic dental treatments are to be opened in major German cities. Finally, M1 is working on its internationalisation. The first foreign location is to be opened in Vienna in the second half of 2018.
“The market for plastic and aesthetic treatments continues to offer significant growth potential to the M1 Group. This applies to our existing treatments and, of course, to new markets. With our strategy – top-class medicine at a fair price – we will continue to promote innovations and actively develop markets in the future,” says Patrick Brenske, member of the Management Board of M1 Kliniken AG. “We will also roll out our business model internationally and make M1 the leading beauty brand in Europe.“